\n\n\n\n\t\t\n\t\t\tNeuroVasX\n\t\t\thttp://www.neurovasx.com/\n\t\t
\n\t\t\n\t\t\tWatch Company\n\t\t\tGet Widget\n\t\t
\n\tNeuroVasX aims to develop and commercialize unique technologies and methodologies for the improved treatment and long term care of stroke patients.
NeuroVasx, Inc. was founded in 1997 to produce...More»
NeuroVasX aims to develop and commercialize unique technologies and methodologies for the improved treatment and long term care of stroke patients.
NeuroVasx, Inc. was founded in 1997 to produce unique diagnostic and therapeutic devices for the neurovascular embolization market. Utilizing unique materials, NeuroVasx\'s products are intended for the treatment of intracranial aneurysms that, because of their morphology, location, or patients general medical condition, are considered high risk for management by traditional operative techniques.«Less
Overview
\n\t\t\t\tLocation: \tMaple Grove, MN, United States\n
\n\t\t\t\tIndustry: Medical Devices & Equipment
\n\t\t\t\tEmployees: 18
\n\t\t\t\tTags:\n\t\t\t\tstroke treatment,\n\t\t\t\tstroke,\n\t\t\t\ttreatment,\n\t\t\t\ttherapeutic devices,\n\t\t\t\tdiagnostic,\n\t\t\t\tcerebral,\n\t\t\t\tembolization,\n\t\t\t\tneurovascular embolization,\n\t\t\t\taneurysms,\n\t\t\t\tneurovascular\n\t\t\t\t
\n\t\t\tFinancials
\n\t\t\t\tLatest Funding: Series C - $8.5M (12/2007)
\n\t\t\t\tInvestors:\n\t\t\t\t\t\n\t\tSF Holdings\n\t\t\t\t
\n\t\t\tMarket
\n\t\t\t\tCompetitors:\n\t\t\t\t\t\tNfocus Neuromedical,\n\t\t\t\t\t\tPhotoThera\n\t\t\t\t
\n\n\t\t\t\tRelated Companies:\n\t\t\t\t\tConcentric Medical,\n\t\t\t\t\tNfocus Neuromedical,\n\t\t\t\t\tNeuroVista\n\t\t\t\t
\n\t\t\t